A federal judge in New Jersey has dismissed more than 100 lawsuits alleging Merck & Co.’s osteoporosis drug Fosamax causes bone fractures.

U.S. District Judge Joel Pisano held that his ruling in a bellwether case last June, Glynn v. Merck, that the nature of the claim was preempted, means the remaining cases need not be tried.